AKR1B10 and hepatocellular carcinoma: Based on the median expression level of AKR1B10 mRNA, hepatocellular carcinoma patients from the TCGA-LIHC cohort were divided into high and low expression groups for correlation analysis with clinicopathological features (Table 2).